Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.97 USD | 0.00% | -5.53% | -21.73% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.73% | 2.14B | |
+17.65% | 85.55B | |
-28.44% | 70.07B | |
+6.76% | 28.95B | |
-7.11% | 17.51B | |
+2.14% | 17.39B | |
+1.67% | 15.38B | |
+6.54% | 13.4B | |
+65.36% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Goldman Sachs Initiates Coverage on Privia Health Group With Buy Rating, $32 Price Target